2021.1– Now AstraZeneca Sr. Brand Manager in Breast Cancer(Brand leader) Brand leader of Zoladex and Arimidex in Breast Cancer and have two subordinates; Pre-launch leader of Zoladex new indication (10.8 BC); Responsible for brand management of Zoladex and Arimidex, developing BSP and BEP of Zoladex and Arimidex; Develop innovative digital and patient centricity strategy incl. PAP and ihospital launch leader of Arimidex; 2021 EC Performance Rating; Marketing Manager Successor; 2022 OBU GM AWARD; 2022 UGW VP AWARD;

2019.1 – 2020.12 Lilly Brand Manager in CNS(Indication Owner) MDD/GAD indication owner of Cymbalta and report to Associate Brand Director. Launch leader of innovative Patients Program in order to extend DOT; Rich experience in leading innovative national summit, KOL management;

2017.1 - 2018.12 Novartis Associate Brand Manager in Respiratory and CNS Responsible for brand management of Onbrez, Exelon and new launch of Exelon Patch, report to Marketing Director. Local contact person of Global Exelon Patch team for China launch and communication, incl. new launch strategy alignment, business forecasting, regulatory management and supply chain. Develop brand strategy and solutions; Organize national events and KEE engagement.

2008.7-2016.12 Boehringer Ingelheim2016.1 -2016.12 Area Development Manager in Respiratory— Responsible for Regional Market Management of SPIRIVA and RESPIMAT Responsible for new launch of RESPIMAT and Regional Market Management of SPIRIVA, report to Eastern Region Marketing Director; In line with the Central Marketing brand strategy, develop and monitor brand activities according to local market; Training and making assessment of Sales Teams; KOL management;2014.1- 2015.12 District Sales Manager in Cardiovascular— Responsible for Sales Team and KOL Management Lead high performance Sales Team (10 people)2008.7- 2013.12 Sales Rep in Cardiovascular— Responsible for Academic promotion